Loading...
OTCM
HAAGF
Market cap121mUSD
, Last price  
USD
Name

Haemato AG

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
19.49%
Rev. gr., 5y
86.99%
Revenues
Net income
CFO

Profile

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
IPO date
Mar 26, 2012
Employees
76
Domiciled in
DE
Incorporated in
DE

Valuation

No data to show